Cargando…
Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240120/ https://www.ncbi.nlm.nih.gov/pubmed/34215363 http://dx.doi.org/10.1016/j.hlc.2021.06.001 |
| _version_ | 1783715152861855744 |
|---|---|
| author | Khan, Hassan Barbhaiya, Chirag |
| author_facet | Khan, Hassan Barbhaiya, Chirag |
| author_sort | Khan, Hassan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8240120 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82401202021-06-29 Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen? Khan, Hassan Barbhaiya, Chirag Heart Lung Circ Commentary Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). 2021-08 2021-06-29 /pmc/articles/PMC8240120/ /pubmed/34215363 http://dx.doi.org/10.1016/j.hlc.2021.06.001 Text en © 2021 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Khan, Hassan Barbhaiya, Chirag Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen? |
| title | Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen? |
| title_full | Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen? |
| title_fullStr | Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen? |
| title_full_unstemmed | Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen? |
| title_short | Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen? |
| title_sort | atrial fibrillation in covid-19: therapeutic target or grave omen? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240120/ https://www.ncbi.nlm.nih.gov/pubmed/34215363 http://dx.doi.org/10.1016/j.hlc.2021.06.001 |
| work_keys_str_mv | AT khanhassan atrialfibrillationincovid19therapeutictargetorgraveomen AT barbhaiyachirag atrialfibrillationincovid19therapeutictargetorgraveomen |